EpiCast Report: Atopic Dermatitis - Epidemiology Forecast to 2024 Now Available at iData Insights EpiCast Report: Atopic Dermatitis - Epidemiology Forecast to 2024 Summary Atopic dermatitis or atopic eczema is the most common type of eczema. Atopic dermatitis is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Though the condition affects people of all ages, it is primarily common among infants and children. Risk factors for atopic dermatitis are broadly classified as modifiable and non-modifiable. Modifiable risk factors include inhalant allergens, food allergens, and newborns not being exclusively breastfed; non-modifiable risk factors include young age and genetics or heritability. In addition, the most common comorbidities associated with the atopic dermatitis such as atopic disorders and psychological disorders contribute significantly to the clinical occurrence of atopic dermatitis. GlobalData epidemiologists forecast that the one-year total prevalent cases of atopic dermatitis in the 9MM will increase from 66,289,178 cases in 2014 to 67,630,097 cases in 2024 with an annual growth rate (AGR) of 0.20%. In the 9MM, India will have the highest number of one-year total prevalent cases of atopic dermatitis with 23,496,094 cases in 2024, followed by the US and China. GlobalData epidemiologists forecast the prevalent cases of atopic dermatitis in the 9MM from 2014 2024 using country-specific studies that provided one-year total prevalence of atopic dermatitis in these markets obtained through symptom-based surveys. Furthermore, GlobalData epidemiologists selected nationally representative studies that provided data on distribution of atopic dermatitis severity in the 9MM. Moreover, GlobalData epidemiologists made sure that the selected nationally representative and country-specific studies assessed the atopic dermatitis prevalence, based on active symptoms during the past year in these markets. Scope - The Atopic Dermatitis EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for atopic dermatitis in the nine major markets (9MM) (US, France, Germany, Italy, Spain, UK, Japan, China, and India). It includes a 10-year epidemiological forecast of the one-year prevalent cases of atopic dermatitis segmented by sex, age (in one-year increments beginning at 0 and ending at 19 years and also in five-year increments beginning at 20 years and ending at =85 years), and severity in these markets. - The Atopic Dermatitis epidemiology report is written and developed by Masters- and PhD-level epidemiologists. - The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 10MM. Reasons to buy The Atopic Dermatitis EpiCast report will allow you to - - Develop business strategies by understanding the trends shaping and driving the global atopic dermatitis market. - Quantify patient populations in the global atopic dermatitis market to improve product design, pricing, and launch plans. - Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for atopic dermatitis therapeutics in each of the markets covered. Browse Complete Report with TOC @ http://idatainsights.com/reports-landing-page.php?id=101888/governancerisk-and-compliance-the-macau-insurance-industry To Get Sample Copy of Report visit @ http://idatainsights.com/reports-landing-page.php?id=101888/governancerisk-and-compliance-the-macau-insurance-industry Table of Contents 1 Table of Contents 1 Table of Contents 4 1.1 List of Tables 6 1.2 List of Figures 6 2 Introduction 7 2.1 Catalyst 7 2.2 Related Reports 7 2.3 Upcoming Related Reports 8 3 Epidemiology 9 3.1 Disease Background 9 3.2 Risk Factors and Comorbidities 9
1
3.3 Global Trends 11 3.3.1 US 11 3.3.2 France 11 3.3.3 Germany 12 3.3.4 Italy 12 3.3.5 Spain 13 3.3.6 UK 13 3.3.7 Japan 13 3.3.8 China 14 3.3.9 India 14 3.4 Forecast Methodology 14 3.4.1 Sources Used 18 3.4.2 Sources Not Used 22 3.4.3 Forecast Assumptions and Methods 23 3.5 Epidemiological Forecast for Atopic Dermatitis (2014-2024) 24 3.5.1 One-Year Total Prevalent Cases of Atopic Dermatitis 24 3.5.2 Age-Specific One-Year Total Prevalent Cases of Atopic Dermatitis 25 3.5.3 Sex-Specific One-Year Total Prevalent Cases of Atopic Dermatitis 27 3.5.4 Age-Standardized One-Year Total Prevalence of Atopic Dermatitis 29 3.5.5 One-Year Total Prevalent Cases of Atopic Dermatitis by Severity 30 3.6 Discussion 32 3.6.1 Epidemiological Forecast Insight 32 3.6.2 Limitations of the Analysis 32 3.6.3 Strengths of the Analysis 33 4 Appendix 34 4.1 Bibliography 34 4.2 About the Authors 38 4.2.1 Epidemiologists 38 4.2.2 Reviewers 38 4.2.3 Global Director of Therapy Analysis and Epidemiology 39 4.2.4 Global Head of Healthcare 39 4.3 About GlobalData 40 4.4 About EpiCast 40
2
4.5 Disclaimer 41 Read More @ http://idatainsights.com/reports-landing-page.php?id=101888/governance-risk-and-compliance-themacau-insurance-industry About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.
Contact Us: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com
About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects.
3